期刊
WIRES MECHANISMS OF DISEASE
卷 14, 期 1, 页码 -出版社
WILEY
DOI: 10.1002/wsbm.1538
关键词
Tet(X); tetracycline; tigecycline resistance; transferability
资金
- National Science Fund for Distinguished Young Scholar [32125003]
- National Natural Science Foundation of China [31830001]
- Guangdong Major Project of Basic and Applied Basic Research [2020B0301030007]
- Program for Innovative Research Team in the University of Ministry of Education of China [IRT_17R39]
- Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2019BT02N054]
- 111 Project [D20008]
- Natural Science Foundation of Jiangsu Province, China [BK20210803]
Tetracycline and its derivative tigecycline are clinical options against Gram-negative bacterial infections, but the emergence of mobile Tet(X) enzymes poses a challenge to antibacterial therapy and food/environmental security. This review presents various Tet(X) variants, discussing their structure, action, evolutional origin, and potential inhibitors to improve understanding of Tet(X)-mediated tigecycline resistance.
Tetracycline and its derivative tigecycline are clinical options against Gram-negative bacterial infections. The emergence of mobile Tet(X) enzymes that destruct tetracycline-type antibiotics is posing a big challenge to antibacterial therapy and food/environmental securities. Here, we present an update on a growing number of Tet(X) variants. We describe structure and action of Tet(X) enzyme, and discuss the evolutional origin. In addition, potential Tet(X) inhibitors are given. This mini-review might benefit better understanding of Tet(X)-mediated tigecycline resistance. This article is categorized under: Infectious Diseases > Genetics/Genomics/Epigenetics Infectious Diseases > Environmental Factors Infectious Diseases > Molecular and Cellular Physiology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据